(VIANEWS) – Greenhill & Co. (GHL), EastGroup Properties (EGP), Columbia Financial (CLBK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Greenhill & Co. (GHL)
106.2% sales growth and 4.01% return on equity
Greenhill & Co., Inc., an independent investment bank, provides financial and strategic advisory services to corporations, partnerships, institutional investors, and governments worldwide. The company offers advisory services related to mergers and acquisitions, divestitures, restructurings, financings, private capital raising, and other similar transactions. It also advises clients on strategic matters, including activist shareholder defense, special committee projects, licensing deals, and joint ventures; and valuation, negotiation tactics, industry dynamics, structuring alternatives, and timing and pricing of transactions, as well as financing alternatives. In addition, the company provides restructuring advisory services to debtors, creditors, governments, and other stakeholders, and acquirers of distressed companies and assets; and advice on restructuring alternatives, capital structures, and sales or recapitalizations. Further, it assists clients in identifying and capitalizing on incremental sources of value; and on court-assisted reorganizations by developing and seeking approval for plans of reorganization, as well as the implementation of such plans. Additionally, the company advises on private placements of debt and structured equity, refinancing of existing debt facilities, negotiating the modification, and amendment of covenants, as well as acts as an independent advisor. It also offers financial advisory services to pension funds, endowments, and other institutional investors on transactions involving alternative assets; and advice to alternative asset fund sponsors for private capital raising, financing, restructuring, liquidity options, valuation, and related services. The company was founded in 1996 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Greenhill & Co. has a trailing twelve months EPS of $1.69.
PE Ratio
Greenhill & Co. has a trailing twelve months price to earnings ratio of 5.17. Meaning, the purchaser of the share is investing $5.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.01%.
Moving Average
Greenhill & Co.’s value is way below its 50-day moving average of $11.45 and below its 200-day moving average of $9.33.
Yearly Top and Bottom Value
Greenhill & Co.’s stock is valued at $8.74 at 06:22 EST, way under its 52-week high of $16.37 and way higher than its 52-week low of $5.65.
Revenue Growth
Year-on-year quarterly revenue growth declined by 20.3%, now sitting on 242.98M for the twelve trailing months.
2. EastGroup Properties (EGP)
14.2% sales growth and 10.57% return on equity
EastGroup Properties, Inc. (NYSE: EGP), an S&P MidCap 400 company, is a self-administered equity real estate investment trust focused on the development, acquisition and operation of industrial properties in major Sunbelt markets throughout the United States with an emphasis in the states of Florida, Texas, Arizona, California and North Carolina. The Company's goal is to maximize shareholder value by being a leading provider in its markets of functional, flexible and quality business distribution space for location sensitive customers (primarily in the 15,000 to 70,000 square foot range). The Company's strategy for growth is based on ownership of premier distribution facilities generally clustered near major transportation features in supply-constrained submarkets. EastGroup's portfolio, including development projects and value-add acquisitions in lease-up and under construction, currently includes approximately 45.7 million square feet.
Earnings Per Share
As for profitability, EastGroup Properties has a trailing twelve months EPS of $4.49.
PE Ratio
EastGroup Properties has a trailing twelve months price to earnings ratio of 35.33. Meaning, the purchaser of the share is investing $35.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.57%.
3. Columbia Financial (CLBK)
9% sales growth and 8.08% return on equity
Columbia Financial, Inc. operates as the bank holding company for Columbia Bank that provides financial services to businesses and consumers in the United States. The company offers non-interest-bearing demand deposits, such as individual and commercial checking accounts; interest bearing demand accounts comprising interest earning checking accounts and municipal accounts; and savings and club accounts, money market accounts, and certificates of deposit. It also provides loans, including multifamily and commercial real estate loans, commercial business loans, one- to four-family residential loans, construction loans, home equity loans and advances, and other consumer loans that include automobiles and personal loans, as well as unsecured and overdraft lines of credit. In addition, the company offers title insurance products; wealth management services; and cash management services, including remote deposit, lockbox service, and sweep accounts. As of December 31, 2020, it operated 61 full-service banking offices in twelve of New Jersey's 21 counties. The company was founded in 1927 and is headquartered in Fair Lawn, New Jersey. Columbia Financial, Inc. is a subsidiary of Columbia Bank MHC.
Earnings Per Share
As for profitability, Columbia Financial has a trailing twelve months EPS of $0.77.
PE Ratio
Columbia Financial has a trailing twelve months price to earnings ratio of 24.6. Meaning, the purchaser of the share is investing $24.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.08%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 291.69M for the twelve trailing months.
Yearly Top and Bottom Value
Columbia Financial’s stock is valued at $18.94 at 06:22 EST, way below its 52-week high of $22.86 and way above its 52-week low of $16.13.
4. Haemonetics Corporation (HAE)
8.9% sales growth and 12.71% return on equity
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Haemonetics Corporation has a trailing twelve months EPS of $2.12.
PE Ratio
Haemonetics Corporation has a trailing twelve months price to earnings ratio of 37.33. Meaning, the purchaser of the share is investing $37.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.71%.
Sales Growth
Haemonetics Corporation’s sales growth is 9.3% for the present quarter and 8.9% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 1.13B for the twelve trailing months.
